Abacavir Sulfate CAS Number 188062-50-2
Wiki Article
Abacavir sulfate, chemically defined as CAS number 188062-50-2, is a potent HIV medication. It suppresses the multiplication of the human immunodeficiency virus (HIV) by stopping the viral enzyme reverse transcriptase. This enzyme is crucial in the HIV life cycle, allowing the virus to integrate its genetic material into the host's DNA. Abacavir sulfate is typically administered in combination with other antiretroviral drugs as part of a comprehensive treatment regimen for HIV infection.
Abarelix : Chemical Identifier 183552-38-7
Abarelix, also known by its chemical identifier 183552-38-7, is a/represents/serves as a gonadotropin-releasing hormone (GnRH) antagonist. It functions by/operates through/acts upon blocking the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. This ultimately reduces/suppresses/minimizes testosterone ALENDRONATE SODIUM 121268-17-5 production in men, making it a valuable treatment option for prostate cancer. Abarelix is typically administered/delivered/infused as an injection, usually on a monthly basis.
Abiraterone Acetate: Chemical Identity
Abiraterone acetate functions as the medication utilized in the handling of terminal cancer. It substance intervenes by blocking an catalyst known as 17-alpha-hydroxylase/17,20-lyase, which then is the synthesis of androgens, hormones held accountable for fueling prostate cancer growth. CAS Registry Number 154229-18-2 serves the unique code of abiraterone acetate, guaranteeing its accurate identification within research communities.
Examination of Abacavir Sulfate's Chemical Properties
Abacavir sulfate, with the chemical identifier CAS 188062-50-2, acts as a vital component in the treatment of HIV infection. This potent antiretroviral agent effectively inhibits the replication of the human immunodeficiency virus (HIV). Abacavir sulfate falls under the class of nucleoside reverse transcriptase inhibitors (NRTIs).
Its chemical structure encompasses a complex arrangement of elements. The molecule displays characteristic physicochemical properties that contribute to its biological activity and therapeutic efficacy.
Comprehending the chemical profile of abacavir sulfate offers valuable insights into its mechanism of action, pharmacokinetics, and potential interactions with other medications.
Pharmaceutical Compound Identification: Abaarelix (CAS 183552-38-7)
Abaarelix, identified by the CAS registry number 183552-38-7, functions as a significant pharmaceutical compound within the realm of medicine. Its primary functionality revolves around the manipulation of hormone levels, particularly targeting gonadotropin-releasing hormone (GnRH). This specific mechanism makes Abaarelix essential in the management of various diseases, notably those involving androgen-dependent growth or proliferation.
- Studies into Abaarelix have demonstrated its efficacy in alleviating symptoms associated with prostate cancer, endometriosis, and certain types of infertility.
- Moreover, the compound's pharmacokinetic properties have been meticulously evaluated to confirm its safety and tolerability in clinical settings.
As a result, Abaarelix has emerged as a promising therapeutic strategy in the modern medical landscape, delivering hope and improved quality of life to patients grappling with these challenging diseases.
Abiraterone Acetate CAS No. 154229-18-2: Structure and Properties
Abiraterone acetate, identified by the chemical designation CAS No. 154229-18-2, is a potent synthetic substance. It exhibits a complex configuration characterized by a copyright base. This design encompasses multiple functional groups, contributing to its therapeutic properties.
Abiraterone acetate is a non-copyrightal restrainer of the enzyme 17α-copyrightogenic acute regulatory protein (CYP17A1), which plays a crucial role in the synthesis of androgens, primarily testosterone. By effectively inhibiting CYP17A1, abiraterone acetate decreases androgen production within the body, thus offering potential therapeutic benefits in the management of prostate cancer.
Report this wiki page